Defined Benefit
Insurance Assets
Nonprofit

Private Equity Shows Persistence Amid Volatile Markets

Private Equity Shows Persistence Amid Volatile Markets
clock
2 min 30 sec

After experiencing severe declines in public equity performance, particularly in 2Q22, investors were bracing for 1Q22 private equity returns. While the public markets declined about 5% in 1Q, private equity’s fall of 1.5% was relatively muted. Private equity returns often exhibit a smoothing effect, where declines are not as sharp as those experienced in the public markets. Venture capital and growth equity experienced the sharpest drops in 1Q, given their technology focus as well as post-IPO public equity holdings. Buyouts were nearly flat for the quarter, while credit-oriented strategies saw modest gains.

Despite the pandemic, annual fundraising has been consistent from 2019-2021 within a tight range of $900-$939 billion. Fundraising for 2022 so far is behind the pace of 2021 but is expected to end at similar levels. Fundraising timelines are extending due to a large number of funds in the market and the onset of constrained LP commitment budgets due to the public markets-related “denominator effect,” which is delaying many final closes.

2Q22 Private Equity Activity in Detail

Fundraising: Based on preliminary data, final closes for private equity partnerships in 2Q22 totaled $233 billion of commitments in 486 partnerships. (Unless otherwise noted, all data in this commentary come from PitchBook.) The dollar volume was up 3% from 1Q22, but the number of funds fell 11%. For the first half, 2022 commitments are running 13% behind those of a year ago, with the number of funds down by 39%. While the figures point to a decline from 2021, the first-half results are in fact tracking to match last year’s total because the second half of 2021 weakened as public equity markets grew volatile.

2q22 private equity

Buyouts: New buyout transactions by count fell 12% from 1Q22 to 2,668, and disclosed deal value dropped 42% to $125 billion. YTD numbers also saw declines of 16% in number of investments and 7% in disclosed value. Average buyout prices remained comparable to 2021, with a similar pattern in average leverage multiples.

VC Investments: New rounds of financing in venture capital companies totaled 10,244, with $125 billion of announced value. The number of investments preliminarily fell 24% from 1Q22, and announced value fell 25%. YTD numbers held up stronger, down only 15% for rounds and 13% for disclosed value.

Exits: There were 522 private M&A exits of private equity-backed companies, with disclosed values totaling $122 billion. The preliminary private sale count fell 18% and the announced dollar volume dropped 26%. There were 42 private equity-backed IPOs in 2Q22 raising an aggregate $7 billion, down 7% by count, with issuance being unchanged from 1Q22.

Venture-backed M&A exits totaled 680 transactions with disclosed value of $23 billion. The number of sales declined 12% from 1Q22, and announced value plunged 56%. There were 67 VC-backed IPOs in 2Q22 with a combined float of $10 billion; the count was down 9% and the issuance grew 25%.

Private Equity Performance 1Q22

Returns: With the strong downturn in public equity markets, private equity outperformance has widened given private equity’s more gradual quarterly mark-to-market valuation methodology.

Posted by

Share
Share on facebook
Share on twitter
Share on linkedin
Related Posts
Defined Benefit

PCE and CPI: What’s the Difference?

Fanglue Zhou
Fanglue Zhou explains how CPI and PCE differ and why the Fed prefers the PCE.
Defined Benefit

Changing Horses Midstream: Why We Released Preliminary 2023 CMAs Now

Jay Kloepfer
Jay Kloepfer explains why we released the preliminary 2023-2032 Capital Markets Assumptions.
Defined Benefit

Private Real Estate Strong; REITs Lag Equities

Munir Iman
Private real estate performed well in 2Q22 while REITs lagged equities. Real assets saw widespread drops.
Defined Benefit

Tough Environment Leads to Losses for Hedge Fund Managers

Joe McGuane
Joe McGuane analyzes hedge fund and MAC performance in 2Q22.
Defined Benefit

Private Credit Interest Still High Despite Illiquidity Premium Close to Zero

Catherine Beard
Catherine Beard analyzes the performance of private credit in 2Q22 and explains what is happening with its illiquidity premium.
Defined Benefit

Recession—Are We There Yet?

Jay Kloepfer
Jay Kloepfer analyzes the U.S. and global economies in 2Q22 and explains why we are not technically in a recession.
Defined Benefit

The Fading Unicorn: How Volatility, Inflation, and Rate Hikes Impact Venture Capital

Ashley Kahn
Ashley Kahn explains the impact of rising inflation, interest rate hikes, and market volatility on venture capital portfolios.
Defined Benefit

Bubbles Bursting Everywhere

Janet Becker-Wold
Janet Becker-Wold explains how recent bubbles inflated and what their popping means for institutional investors.
Defined Benefit

Few Bright Spots as Markets Continue to Drop

Kristin Bradbury
Kristin Bradbury recaps how the global markets performed in 2Q22.
Defined Benefit

Global Challenges Mount

Kristin Bradbury
Kristin Bradbury analyzes the global economy in 2Q22.

Callan Family Office

You are now leaving Callan LLC’s website and going to Callan Family Office’s website. Callan Family Office is not affiliated with Callan LLC.  Callan LLC has licensed the Callan® trademark to Callan Family Office for use in providing investment advisory services to ultra-high net worth clients, family foundations, and endowments. Callan Family Office and Callan LLC are independent, unaffiliated investment advisory firms separately registered with the Securities and Exchange Commission under the Investment Advisers Act of 1940.

Callan LLC is not responsible for the services and content on Callan Family Office’s website. Inclusion of this link does not constitute or imply an endorsement, sponsorship, or recommendation by Callan LLC of their website, or its contents, and Callan LLC is not responsible or liable for your use of it. When visiting their website, you are subject to Callan Family Office’s terms of use and privacy policies.